[Special Stock] NanoCMS Advances US Market with COVID-19 Eradication Lamp... Recognized by International Academic Journals as Eco-Friendly

[Asia Economy Reporter Hyunseok Yoo] The stock price of Nano CMS is soaring. The news that its harmless far-ultraviolet (Far UVC, 200~230nm) wavelength technology, which eradicates the COVID-19 virus suspended as aerosols in indoor air, has been recognized by a global academic journal appears to have influenced the stock price.

As of 2:05 PM on the 3rd, Nano CMS was trading at 22,450 KRW, up 16.02% (3,100 KRW) compared to the previous trading day.

On the 2nd (local time), the German biomedical international academic journal Clinical Laboratory published a paper titled "The Effect of Nano CMS's Microplasma Far Ultraviolet UVC 222nm (nanometer) Lamp on COVID-19."

The paper involved collaboration from Seoul National University College of Veterinary Medicine's Microbiology Department, Jeonbuk National University College of Veterinary Medicine's Zoonotic Infectious Disease Research Institute, Inje University Department of Biotechnology, and the University of Illinois Department of Electrical and Computer Engineering.

The research team irradiated gauze cultured with a high concentration (initial concentration 4.5 log10TCID50/㎖) of COVID-19 virus with a 222nm lamp at a fixed distance. The degree of virus elimination was measured after 10, 20, 30, 60, 120, 300, and 600 seconds. The results confirmed that from 30 seconds of irradiation, 99.9% of the virus was removed, and complete inactivation was achieved from 60 seconds onward.

Nano CMS developed materials capable of producing the 222nm wavelength through about 10 years of nano-based chemical structure design. In cooperation with the US technology company Eden Park Illumination, they succeeded in developing indoor-use bulbs, downlights, and bar-shaped lamps with the 222nm wavelength applying microplasma technology. The developed lamps can be used for about one year based on 8 hours of daily use.

In addition to the publication in Clinical Laboratory, Nano CMS has demonstrated its outstanding technological capabilities of the 222nm technology through various empirical experiments. Previously released UVC lamps contained strong toxicity and mercury, causing environmental issues. Nano CMS’s microplasma far-ultraviolet flat 222nm lamps are eco-friendly, easy to apply, harmless to humans, and have secured mass production capability.

Nano CMS will officially begin sales of the 222nm lamps in the US market starting this October. Interest in the 222nm lamps is reportedly high as the number of confirmed COVID-19 cases surged following the relaxation of indoor mask mandates in the US.